Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Neoplasms, Skull Base

pyrroles has been researched along with Neoplasms, Skull Base in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Angenstein, F; John, P; Kesseler, C; Kirches, E; Liebich, J; Mawrin, C; Sahm, F; Sandalcioglu, IE; Scherlach, C; Schnabel, S; Waldt, N1
Bay, JO; Bertucci, F; Blay, JY; Bompas, E; Bonneville-Levard, A; Chauffert, B; Chevreau, C; Cupissol, D; Duffaud, F; Fabbro, M; Feuvret, L; Le Cesne, A; Lebellec, L; Mir, O; Noel, G; Penel, N; Saada-Bouzid, E; Vauleon, E; Vinceneux, A1
Golinelli, G; Pia, F; Rosa, MS; Toso, A; Valletti, PA1

Other Studies

3 other study(ies) available for pyrroles and Neoplasms, Skull Base

ArticleYear
AKT1
    Neuropathology and applied neurobiology, 2022, Volume: 48, Issue:2

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Meningeal Neoplasms; Meningioma; Mice; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Skull Base Neoplasms

2022
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 79

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Chordoma; Erlotinib Hydrochloride; Female; France; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrroles; Retrospective Studies; Sirolimus; Skull Base Neoplasms; Sorafenib; Sunitinib; Treatment Outcome; Young Adult

2017
Skull Base Metastasis From Occult Renal Cell Carcinoma.
    The Journal of craniofacial surgery, 2018, Volume: 29, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Everolimus; Humans; Immunotherapy; Indoles; Kidney Neoplasms; Male; Neoplasms, Unknown Primary; Nephrectomy; Niacinamide; Phenylurea Compounds; Pyrroles; Skull Base Neoplasms; Sorafenib; Sunitinib

2018